`McCurdy, Barbara; Sommers, Erin; DeRoo, Pier
`White, Brandon (Perkins Coie)
`IPR2018-01403
`Wednesday, March 6, 2019 5:11:03 PM
`2019-03-06 Mylan Response to Patent Owner Objections to Evidence.pdf
`Greb Declaration.pdf
`Replacement Exhibit 1055 - Rock Declaration.pdf
`Replacement Exhibit 1010 - Clinical Trials.pdf
`Replacement Exhibit 1029 - Nugteren-Huying 1990.pdf
`Replacement Exhibit 1011 - ICH Guideline.pdf
`
`From:
`To:
`Cc:
`Subject:
`Date:
`Attachments:
`
`EXTERNAL Email:
`
`Counsel,
`
`Please see the attached Petitioner’s Response to Patent Owner Objections to Petitioner’s Exhibits,
`Greb Declaration, and Replacement Exhibits 1010, 1011, 1029, and 1055, being served today in
`IPR2018-01403 in accordance with 37 C.F.R. § 42.64(b)(2).
`
`Regards,
`Emily
`
`
`Emily Greb | Perkins Coie LLP
`COUNSEL
`33 East Main Street Suite 201
`Madison, WI 53703-3095
`D. +1.608.663.7494
`F. +1.608.283.4494
`E. EGreb@perkinscoie.com
`
`
`NOTICE: This communication may contain privileged or other confidential information. If you have received it in error, please advise the
`sender by reply email and immediately delete the message and any attachments without copying or disclosing the contents. Thank you.
`
`Page 1 of 1
`
`Biogen Exhibit 2049
`Mylan v. Biogen
`IPR2018-01403
`
`